Erenumab (Aimovig) was the first anti-CGRP agent approved by the FDA for migraine prophylaxis.
Ahmed Banawan, PharmD
Advertisement
Articles by Ahmed Banawan, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Under Pressure: A Brief Overview of the Updated Hypertension Guidelines
2
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
3
Biosimilar Stivant Shows Noninferior Efficacy and Comparable Safety to Reference Bevacizumab
4
Current and Emerging BCMAxCD3 Bispecifics
5
